A Study to Assess the Effect of a Strong CYP3A Inhibitor, on Surufatinib in Healthy Subjects
Status:
Completed
Trial end date:
2021-01-19
Target enrollment:
Participant gender:
Summary
This study will be a 2-period study conducted with 14 healthy male or female subjects.
Subjects will be administered surufatinib alone in Period 1 and in combination with
itraconazole in Period 2.